🔍

Bhagiradha Chemicals & Industries Limited (BHAGCHEM)

₹213.08 -3.35% last close, 16 Oct

📊 NSE: BHAGCHEM 🏢 Pesticides / Agrochemicals - Indian 📢 Latest filing: 05 Oct 2026 📝 Analysis written: 13 Dec 2025

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Bhagiradha Chemicals' revenue was ₹195 Cr (+57.6% year on year, +23.4% on the previous quarter), and net profit ₹13.3 Cr (+235.0% year on year); the operating margin was 15.7%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹195	+57.6%	+23.4%
Operating profit	₹30.5	+239.5%	+57.1%
Net profit	₹13.3	+235.0%	+227.5%
EPS (₹)	1.03	+232.3%	+232.3%
Operating margin	15.7%	—	—

Full quarterly financials → Results calendar →

BHAGCHEM delivery percentage

NSE end-of-day data for Fri, 16 Oct 2026

On Fri, 16 Oct 2026, 55.08% of the BHAGCHEM shares traded on NSE were taken to delivery, against the stock's own 20-session average of 62.4%. That is close to its usual level.

55.08%Delivery, 16 Oct

62.4%Own 20-session average

1.3×Volume vs its average

₹213.08NSE close · -3.35%

Delivery in the last 5 sessions: 53.5% · 52.5% · 50.2% · 53.0% · 55.1%

Delivery across the market →

A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed

📢 Recent Corporate Announcements

Bhagiradha Chemicals Submits Depository Compliance Certificate for Q2 FY27

🟡 NEUTRAL ⭐ 1/10

ROUTINE 📅 05 Oct 2026, 11:35 PM

Bhagiradha Chemicals & Industries Limited has submitted its compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate, issued by Registrar and Share Transfer Agent XL Softech Systems Limited, confirms that dematerialization requests received during the period were processed within the stipulated 15 days. Security certificates received were confirmed to depositories, cancelled, and listed appropriately. This is a standard quarterly administrative filing with no financial or operational impact.

Compliance certificate submitted under Regulation 74(5) for the quarter ended September 30, 2026
Issued by Registrar and Share Transfer Agent XL Softech Systems Limited on October 05, 2026
Confirmation that dematerialization requests and member register substitutions were completed within 15 days

💡 This is a routine administrative compliance filing; investors should track upcoming Q2 FY27 financial results and operational updates.

Ind-Ra Assigns 'IND BBB+/Stable' to Bhagiradha Chem's Arm for ₹600 Cr Facilities

🟢 POSITIVE ⭐ 7/10

REGULATORY 📅 21 Aug 2026, 04:10 PM

India Ratings and Research (Ind-Ra) has assigned 'IND BBB+/Stable/IND A2+' to the ₹600 Cr (INR 6,000 million) bank loan facilities of Bheema Fine Chemicals Private Limited, a wholly owned subsidiary of Bhagiradha Chemicals. The rating is backed by an unconditional and irrevocable corporate guarantee from the parent. Ind-Ra highlighted the ongoing ₹950 Cr total capex outlay to add 9,000 MTPA capacity, of which ₹600 Cr was incurred by June 2026. The expansion will lift aggregate capacity from 3,250 MTPA to 12,250 MTPA, with the subsidiary expected to contribute ~70% of consolidated business upon full ramp-up.

Ind-Ra assigned 'IND BBB+/Stable/IND A2+' rating for ₹600 Cr (INR 6,000 million) bank loan facilities of subsidiary Bheema Fine Chemicals.
Parent BCIL provides an unconditional and irrevocable corporate guarantee for the subsidiary's facilities.
Total capex outlay of ₹950 Cr (₹9,500 million) across FY24-FY28, with ₹600 Cr already incurred by end-June 2026.
Capex will expand group technical manufacturing capacity by 9,000 MTPA to 12,250 MTPA, contributing ~70% to consolidated revenue upon full commissioning.

💡 Track the commissioning and utilization ramp-up of Phase 2 capacity across FY27-FY28 and monitor debt reduction as operating cash flows normalize.

Bhagiradha Chemicals to Attend Equirus Annual India Conference on August 14, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 10 Aug 2026, 06:44 PM

Bhagiradha Chemicals has scheduled 1x1 and group meetings with institutional investors for August 14, 2026, in Mumbai. The interaction occurs as the company navigates a significant growth phase, characterized by an ₹800+ Cr expansion at its Bheema Fine Chemicals subsidiary. While TTM revenue stands at ₹536 Cr, the company is currently trading at a high P/E of 204.7, reflecting market expectations for the new 9,002 MT capacity. No unpublished price sensitive information is expected to be shared during these sessions.

Investor meeting scheduled for August 14, 2026, starting at 10:00 am IST
Participation in the Equirus Annual India Conference in Mumbai for 1x1 and group meetings
Company is executing an ₹800+ Cr expansion, which is approximately 1.5x its TTM revenue of ₹536 Cr
New Bheema Fine Chemicals facility adds 9,002 MT of capacity to the existing operations
Current promoter holding remains stable at 19.6% as of March 2026

💡 Monitor the company's website for any post-conference investor presentations that may provide updates on the utilization levels of the new Bheema facility and the status of 10 new products under development.

58% Revenue Growth in Q1 FY27; EBITDA Jumps 240% on Bheema Plant Ramp-up

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 06 Aug 2026, 06:32 PM

Bhagiradha Chemicals reported a strong Q1 FY27 with consolidated revenue reaching ₹195.0 Cr, a 58% YoY increase. EBITDA surged 240% YoY to ₹30.5 Cr, with margins expanding significantly to 15.7% from 7.3% in the year-ago period. This performance was driven by the ramp-up of the Bheema Fine Chemicals facility, where capacity utilization nearly doubled compared to Q4 FY26. The company also introduced four new mid-to-high value molecules, contributing to a richer product mix and improved realizations.

Revenue from operations grew 58% YoY to ₹195.0 Cr in Q1 FY27.
EBITDA increased 240% YoY to ₹30.5 Cr, with margins expanding by 839 bps to 15.7%.
Profit After Tax (PAT) rose 235% YoY to ₹13.3 Cr, despite higher depreciation and finance costs.
Introduced 4 new molecules in the mid-to-high value segment during the quarter.
Bheema Fine Chemicals facility (9,002 MT capacity) saw utilization nearly double vs Q4 FY26.

💡 Watch for the continued utilization ramp-up at the Bheema facility and the successful commercialization of the remaining 6 out of 10 new products under development to sustain margin expansion.

235% YoY Profit Growth: BHAGCHEM Reports Strong Q1 FY27 Consolidated Results

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 03 Aug 2026, 02:09 PM

Bhagiradha Chemicals reported a robust start to FY27 with consolidated revenue growing 57.5% YoY to ₹195.02 Cr. Net profit surged 235% YoY to ₹13.33 Cr, compared to ₹3.98 Cr in the same quarter last year. The performance indicates strong operating leverage as the Bheema Fine Chemicals subsidiary scales up, with Q1 revenue alone representing 36.4% of the previous TTM revenue. Despite higher finance costs of ₹6.43 Cr, consolidated PBT rose 601% YoY, reflecting improved product realizations and capacity utilization.

Consolidated Revenue from Operations increased 57.5% YoY to ₹195.02 Cr from ₹123.78 Cr.
Consolidated Net Profit grew 235% YoY to ₹13.33 Cr, up from ₹3.98 Cr in Q1 FY26.
Consolidated Profit Before Tax (PBT) reached ₹17.54 Cr, a 601% increase over the ₹2.50 Cr reported in the year-ago period.
Inventory levels for finished goods and WIP increased by ₹50.32 Cr during the quarter, suggesting strong anticipated demand.
Finance costs rose to ₹6.43 Cr from ₹3.26 Cr YoY, reflecting the debt servicing for the ₹800+ Cr Bheema expansion.

💡 Investors should monitor the sustainability of the 15.6% estimated EBITDA margin and the ramp-up progress of the Bheema Fine Chemicals facility. Key risks to watch include the potential regulatory ban on Chlorpyriphos and the impact of high finance costs on net margins.

BHAGCHEM Q1 FY27: Consolidated Revenue up 57% YoY to ₹195 Cr; PBT jumps 7x to ₹17.5 Cr

🟢 POSITIVE ⭐ 7/10

EARNINGS 📅 03 Aug 2026, 02:06 PM

Bhagiradha Chemicals reported a strong start to FY27 with consolidated revenue reaching ₹195.02 Cr, a 57.5% increase over Q1 FY26. Profitability showed a sharp recovery, with Consolidated Profit Before Tax (PBT) rising to ₹17.54 Cr from just ₹2.50 Cr in the year-ago period. This growth is largely driven by the ramp-up of the Bheema Fine Chemicals subsidiary, which added 9,002 MT of capacity. However, finance costs have doubled to ₹6.43 Cr YoY, reflecting the capital-intensive nature of recent expansions.

Consolidated Revenue from Operations grew 57.5% YoY to ₹195.02 Cr from ₹123.78 Cr.
Consolidated Profit Before Tax (PBT) surged to ₹17.54 Cr compared to ₹2.50 Cr in Q1 FY26.
Standalone Net Profit increased to ₹10.68 Cr, up from ₹8.29 Cr in the same quarter last year.
Finance costs rose significantly to ₹6.43 Cr from ₹3.26 Cr YoY, reflecting debt for the Bheema expansion.
Consolidated inventory levels saw a net increase of ₹50.32 Cr during the quarter, indicating production ramp-up.

💡 Monitor the sustainability of operating margins as the Bheema facility scales up and watch for any impact from global agrochemical pricing volatility due to Chinese oversupply.

15% Final Dividend Approved as Bhagiradha Chemicals Concludes 33rd AGM

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 31 Jul 2026, 11:40 PM

Bhagiradha Chemicals & Industries Limited successfully concluded its 33rd Annual General Meeting on July 31, 2026. Shareholders approved all four proposed resolutions with over 99.99% majority, including the adoption of FY26 financial statements and a final dividend of Rs. 0.15 per share. The meeting also confirmed the re-appointment of Director Suresh Kumar Somani and ratified the remuneration for cost auditors for FY27. The total valid votes cast for the resolutions reached 79,556,209.

Final dividend of 15% (Rs. 0.15 per equity share of face value Rs. 1) approved for FY26.
Resolution for adoption of FY26 Audited Financial Statements passed with 99.9962% votes in favour.
Total valid votes cast across all resolutions amounted to 79,556,209.
Cost Auditor remuneration ratified at Rs. 15,000 per annum for the financial year ending March 31, 2027.
Re-appointment of Sri. Suresh Kumar Somani as a Non-Executive Non-Independent Director approved.

💡 Investors should monitor the company's upcoming disclosures for the dividend payment timeline and record date, while focusing on the execution of the Rs 800+ Cr Bheema Fine Chemicals expansion mentioned in previous filings.

15% Dividend Approved at 33rd AGM; FY26 Financials Adopted

🟡 NEUTRAL ⭐ 4/10

ROUTINE 📅 31 Jul 2026, 03:19 PM

Bhagiradha Chemicals concluded its 33rd Annual General Meeting on July 31, 2026, where shareholders approved a final dividend of ₹0.15 per equity share (15% of face value). The company formally adopted its FY26 audited financial statements, which show a TTM revenue of ₹536 Cr and a PAT of ₹18 Cr. Shareholders also ratified the re-appointment of Director Suresh Kumar Somani and the remuneration for Cost Auditors for FY27. Management addressed queries regarding the operations of its wholly-owned subsidiary, Bheema Fine Chemicals, which recently added 9,002 MT of capacity.

Approved a final dividend of ₹0.15 per equity share of ₹1 face value for FY26
Adopted FY26 standalone and consolidated financial statements reporting TTM revenue of ₹536 Cr
Meeting conducted via video conferencing with 78 members present (3 Promoters, 75 Public)
Ratified the remuneration of Cost Auditors for the financial year 2026-27
Confirmed the re-appointment of Sri. Suresh Kumar Somani as a Non-Executive Director

💡 Investors should monitor the ramp-up of the 9,002 MT capacity at the Bheema Fine Chemicals subsidiary and the progress of 10 new products currently under development to improve the current low ROCE of 5.0%.

Bhagiradha Chemicals Schedules 33rd AGM for July 31, 2026; Releases FY26 Annual Report

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 08 Jul 2026, 03:50 PM

Bhagiradha Chemicals & Industries Limited has scheduled its 33rd Annual General Meeting (AGM) for July 31, 2026, at 11:00 a.m. IST via video conferencing. The company has dispatched letters to shareholders who have not registered their email addresses, providing them with the web link to access the full Annual Report for FY 2025-26. This filing is a procedural requirement under SEBI Regulation 36(1)(b). Investors should note the cut-off date for this communication was July 3, 2026.

33rd Annual General Meeting (AGM) to be held on July 31, 2026, via Video Conferencing.
Cut-off date for identifying shareholders without registered emails was July 3, 2026.
Annual Report for FY 2025-26 is now available on the company's website.
Company is currently managing an expansion project valued at ₹800+ Cr at its Bheema Fine Chemicals subsidiary.

💡 Investors should access the Annual Report via the provided link to review management's commentary on the ₹800+ Cr Bheema Fine Chemicals expansion and the status of 10 new products under development.

Bhagiradha Chemicals Reports FY 2025-26 BRSR; Exports at 2.5% of Revenue

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 08 Jul 2026, 02:54 PM

Bhagiradha Chemicals has released its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, reporting a standalone turnover of ₹526.92 Cr. The company remains heavily domestic-focused, with exports contributing only 2.50% of total revenue across 5 international countries. The report details a total permanent workforce of 527 individuals and a net worth of ₹723.56 Cr. While the company identifies emission management and regulatory compliance as key risks, no material stakeholder grievances were reported for the period.

Total turnover for the financial year 2025-26 stood at ₹526.92 Cr.
Exports accounted for a marginal 2.50% of the total revenue.
The company maintains a permanent workforce of 224 employees and 303 workers.
Female representation on the Board of Directors is reported at 28.57%.
The company serves 18 States/UTs in India and 5 international markets.

💡 Investors should focus on the upcoming quarterly results to track the utilization of the 9,002 MT capacity at the Bheema Fine Chemicals subsidiary, as this BRSR is primarily administrative.

BHAGCHEM Announces 15% Final Dividend; 33rd AGM Scheduled for July 31, 2026

🟡 NEUTRAL ⭐ 4/10

ROUTINE 📅 08 Jul 2026, 02:37 PM

Bhagiradha Chemicals & Industries Limited has issued a notice for its 33rd Annual General Meeting (AGM) to be held on July 31, 2026. The board has recommended a final dividend of ₹0.15 per share (15% of face value) for FY 2025-26, representing a total payout of approximately ₹1.95 Cr against a TTM PAT of ₹18 Cr. Key agenda items include the re-appointment of Director Suresh Kumar Somani, whose associated entity Ratnabali Investment holds a 14.07% stake in the company.

Proposed final dividend of ₹0.15 per equity share (15% of ₹1 face value) for FY 2025-26.
33rd Annual General Meeting scheduled for July 31, 2026, via Video Conferencing.
Re-appointment of Sri. Suresh Kumar Somani, representing a 14.07% shareholding through Ratnabali Investment Pvt Ltd.
Ratification of Cost Auditor remuneration at ₹1,25,000 for the financial year 2026-27.
Notice and Annual Report dispatched electronically to members as of the July 03, 2026 record date.

💡 Investors should monitor the AGM for management commentary regarding the utilization of the 9,002 MT capacity at the Bheema Fine Chemicals facility and the status of 10 new products currently under development.

Bhagiradha Chemicals Confirms Compliance with SEBI Demat Regulations for Q1 FY27

🟡 NEUTRAL ⭐ 2/10

REGULATORY 📅 03 Jul 2026, 05:11 PM

Bhagiradha Chemicals & Industries Limited has submitted its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The filing, issued by the Registrar and Share Transfer Agent (RTA) XL Softech Systems Limited, confirms that all share certificates received for dematerialization during the quarter ended June 30, 2026, were processed correctly. The RTA verified that the securities were listed on the stock exchanges and that physical certificates were mutilated and cancelled within the mandated 15-day period. This is a routine administrative filing required for all listed entities in India.

Confirmation of compliance for the quarter ended June 30, 2026
Dematerialization requests processed and confirmed to depositories within 15 days
Physical security certificates mutilated and cancelled after due verification
Registrar and Share Transfer Agent identified as M/s. XL Softech Systems Limited

💡 This is a routine procedural filing. Investors should focus on upcoming quarterly financial results for fundamental performance indicators.

Bhagiradha Chemicals to Close Trading Window from July 1 for Q1 FY27 Results

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 24 Jun 2026, 07:47 PM

Bhagiradha Chemicals & Industries Limited has announced the closure of its trading window starting July 1, 2026, in compliance with SEBI insider trading regulations. This closure is preparatory to the announcement of the company's un-audited standalone and consolidated financial results for the first quarter ending June 30, 2026. The window will remain closed for all designated persons and their immediate relatives until 48 hours after the results are declared. The specific date for the Board of Directors meeting to approve these results will be communicated at a later date.

Trading window closure commences on July 01, 2026, for Q1 FY27 results.
Applies to all designated persons and their immediate relatives under SEBI (Prohibition of Insider Trading) Regulations.
Window remains closed until 48 hours after the declaration of un-audited financial results.
Board meeting date for result approval to be intimated in due course.

💡 This is a routine regulatory announcement with no direct impact on company fundamentals. Investors should watch for the upcoming board meeting date to prepare for the Q1 earnings performance.

Bhagiradha Chemicals Promoters Declare Zero Pledged Shares for FY 2025-26

🟢 POSITIVE ⭐ 4/10

ROUTINE 📅 23 Jun 2026, 04:06 PM

The promoters of Bhagiradha Chemicals & Industries Limited have submitted their annual disclosure under SEBI Takeover Regulations for the financial year ended March 31, 2026. The promoter group collectively holds 2,54,10,000 equity shares, which represents 19.60% of the company's total share capital. Significantly, the promoters declared that they have not made any encumbrance or pledge on these shares, directly or indirectly, during the entire financial year. This filing confirms the absence of promoter-level debt pressure linked to their equity holdings.

Total promoter and promoter group holding stands at 2,54,10,000 shares as of March 31, 2026.
Promoter group shareholding is equivalent to 19.60% of the company's equity.
Declaration confirms zero encumbrance (pledging) of shares during the 2025-26 financial year.
Individual promoter Singavarapu Chandrasekhar holds the largest stake at 12.90% (1,67,27,740 shares).
Greenpath Energy Private Limited is the largest corporate promoter entity with a 3.68% stake.

💡 Investors can take comfort in the fact that the promoter stake is free of any pledges, which reduces the risk of volatility from margin calls. No immediate action is required as this is a routine but positive compliance disclosure.

Bhagiradha Chemicals Clarifies No Undisclosed Information Behind Recent Volume Spurt

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 20 Jun 2026, 10:45 AM

Bhagiradha Chemicals & Industries Limited (BHAGCHEM) has responded to a surveillance query from the National Stock Exchange regarding a significant increase in trading volume. The company clarified that it has disclosed all price-sensitive information in accordance with SEBI Regulation 30. Management stated that there are no pending material events or announcements that would impact the stock's price or volume behavior. Consequently, the company maintains that the recent volume spurt is purely market-driven and outside its control.

Responded to NSE surveillance query dated June 19, 2026, regarding volume spurt
Confirmed adherence to SEBI (LODR) Regulations, 2015 for all disclosures
Stated no undisclosed material information or impending announcements exist
Attributed recent high trading volumes to external market-driven factors

💡 Investors should ignore speculative rumors regarding the volume spike as the company has confirmed no new developments. Focus on fundamental performance and upcoming quarterly results for long-term direction.

View All BHAGCHEM Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

Consolidated revenue grew 37% in FY22 (INR 435.67 Cr) and 15% in FY23 (INR 502.67 Cr). H1FY26 revenue grew 11% YoY compared to H1FY25, driven by increased sales of high-value products.

Geographic Revenue Split

Domestic revenue is projected to grow by 8-9% in FY25, supported by favorable monsoons. Raw material imports from China contribute 20-25% of total purchases, indicating significant global supply chain exposure.

Profitability Margins

FY23 Operating Margin was 15.67% (up from 14.79% in FY22). PAT margin improved 88 bps to 8.21% in FY23. H1FY26 PAT margin was 3.6% (down from 5.2% in H1FY25) due to elevated finance costs.

EBITDA Margin

H1FY26 EBITDA margin was 9.1% (down from 10.1% in H1FY25). While EBITDA grew 11% YoY in absolute terms, margins were squeezed by increased raw material costs in two specific products and the clearance of low-margin inventory.

Capital Expenditure

The company is executing a massive expansion program with total investments exceeding INR 800 Cr through its subsidiary, Bheema Fine Chemicals Private Limited.

Credit Rating & Borrowing

CARE reaffirmed ratings at CARE BBB+; Stable (Long Term) and CARE A2 (Short Term) before they were withdrawn in November 2023 at the company's request. Interest coverage was healthy at 7.51x in FY22.

⚙️ Operational Drivers

Raw Materials

Key raw materials include chemical intermediates for technical products such as Chlorpyriphos, Azoxystrobin, Fluroxypyr, Triclopyr, and Imidacloprid.

Import Sources

Approximately 20-25% of raw materials are imported from China, while 70-75% are sourced from the indigenous Indian market.

Capacity Expansion

The Bheema Fine Chemicals facility in Karnataka has an installed capacity of 9,002 MT with 2 processing blocks and commenced commercial production on March 27, 2024.

Raw Material Costs

Raw material costs for two specific products increased in H1FY26, impacting gross margins. The company uses budgetary controls and management systems to mitigate cost volatility.

Manufacturing Efficiency

The new Bheema facility utilizes automated operations through Distributed Control Systems (DCS) and Zero Liquid Discharge (ZLD) ETP to improve efficiency and compliance.

📈 Strategic Growth

Expected Growth Rate

8-9%

Growth Strategy

Growth will be achieved through the INR 800+ Cr expansion at Bheema Fine Chemicals, which adds 9,002 MT of capacity and provides higher backward integration. The company is also developing 10 new products to diversify its portfolio and reduce reliance on Chlorpyriphos.

Products & Services

Technical-grade agrochemicals including Chlorpyriphos-Technical, Fluroxypyr-Technical, Triclopyr-Technical, Imidacloprid-Technical, Azoxystrobin-Technical, and Fipronil.

New Products/Services

The company has 10 new products under development to expand its existing portfolio of over 13 products.

Market Expansion

Expansion is focused on the Kadechur Industrial Area in Karnataka through the Bheema subsidiary, targeting both domestic and alternative global markets.

Strategic Alliances

The company signed an MOU with the Government of Karnataka for setting up the manufacturing unit in the Kadechur industrial area.

🌍 External Factors

Industry Trends

The agrochemical industry is seeing a shift toward backward integration and automation to combat pricing pressure. Domestic demand remains healthy at 8-9% growth despite global headwinds.

Competitive Landscape

Fierce competition exists from both domestic players and Chinese exporters who are currently offloading surplus inventory in global markets.

Competitive Moat

Moats include established R&D capabilities and backward integration at the new Bheema facility, which are sustainable as they lower production costs and allow for rapid product launches.

Macro Economic Sensitivity

Domestic growth is 8-9% sensitive to monsoon performance and reservoir levels which drive agricultural activity.

Geopolitical Risks

Trade dynamics with China are a major risk, as Chinese oversupply heightens competition in global markets and keeps technical prices subdued.

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to strict pollution norms and product-specific regulations, such as the potential ban on Chlorpyriphos by the Ministry of Agriculture.

Environmental Compliance

The company has invested in Zero Liquid Discharge (ZLD) systems and follows Miyawaki Plantation methodology, with 60% of plant area covered by a green belt.

Taxation Policy Impact

The company benefits from a lower tax rate of 17.16% for its newly established manufacturing unit under Bheema Fine Chemicals.

Legal Contingencies

A delay in receiving Environment Clearance (EC) for the Bheema project resulted in a one-year time overrun and an INR 30 Cr cost overrun.

⚠️ Risk Analysis

Key Uncertainties

The primary uncertainty is the potential ban on Chlorpyriphos, which contributed INR 95.8 Cr (22%) to revenue in FY22. Pricing pressure from China also remains a key risk.